AMPIO PHARMACEUTICALS, INC.: 10-K filed 2017-03-16

Name: AMPIO PHARMACEUTICALS, INC.: 10-K filed 2017-03-16
Creator: AMPIO PHARMACEUTICALS, INC.
License: https://creativecommons.org/licenses/by/4.0/

What AMPIO PHARMACEUTICALS, INC. reported in its annual report filed 2017-03-16 (fiscal FY 2016): 28 published measures, 108 facts as tagged in accession 0001144204-17-015100.

This filing

Form: 10-K (annual report)
Filed: 2017-03-16
Fiscal period: fiscal FY 2016
Accession: 0001144204-17-015100 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All AMPIO PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-12-31	13,595,786	USD
At 2015-12-31	50,418,593	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2016-12-31	6,961,475	USD
At 2015-12-31	12,491,605	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2016-12-31	6,634,311	USD
At 2015-12-31	36,999,158	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-12-31	4,894,834	USD
At 2015-12-31	15,998,392	USD
At 2014-12-31	50,320,656	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-19,163,629	USD	366
2015-01-01 to 2015-12-31	-32,010,242	USD	365
2014-01-01 to 2014-12-31	-38,125,415	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-14,624,972	USD	366
2015-01-01 to 2015-12-31	-26,444,110	USD	365
2014-01-01 to 2014-12-31	-30,740,583	USD	365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	6,844	USD	366
2015-01-01 to 2015-12-31	110,495	USD	365
2014-01-01 to 2014-12-31	8,668,351	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	3,528,258	USD	366
2015-01-01 to 2015-12-31	21,157,938	USD	365
2014-01-01 to 2014-12-31	68,930,692	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-6,844	USD	366
2015-01-01 to 2015-12-31	-18,076,546	USD	365
2014-01-01 to 2014-12-31	-14,178,902	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-12-31	-153,078,441	USD
At 2015-12-31	-133,914,812	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2016-01-01 to 2016-12-31	USD	366
2015-01-01 to 2015-12-31	USD	365
2014-01-01 to 2014-12-31	USD	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2016-12-31	7,980,011	USD
At 2015-12-31	9,187,620	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	1,516,033	USD	366
2015-01-01 to 2015-12-31	4,957,785	USD	365
2014-01-01 to 2014-12-31	7,176,865	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-12-31	5,402,167	USD
At 2015-12-31	29,228,422	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-12-31	2,134,566	USD
At 2015-12-31	5,515,113	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	2,948,219	USD	92
2016-01-01 to 2016-12-31	17,082,354	USD	366
2016-07-01 to 2016-09-30	3,343,751	USD	92
2016-04-01 to 2016-06-30	4,367,961	USD	91
2016-01-01 to 2016-03-31	6,422,423	USD	91
2015-10-01 to 2015-12-31	7,294,060	USD	92
2015-01-01 to 2015-12-31	24,167,571	USD	365
2015-07-01 to 2015-09-30	5,300,368	USD	92
2015-04-01 to 2015-06-30	5,779,435	USD	91
2015-01-01 to 2015-03-31	5,793,708	USD	90
2014-01-01 to 2014-12-31	31,448,019	USD	365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	1,306,631	USD	92
2016-07-01 to 2016-09-30	1,555,527	USD	92
2016-04-01 to 2016-06-30	1,563,013	USD	91
2016-01-01 to 2016-03-31	2,110,896	USD	91
2015-10-01 to 2015-12-31	2,869,794	USD	92
2015-07-01 to 2015-09-30	1,646,625	USD	92
2015-04-01 to 2015-06-30	2,666,196	USD	91
2015-01-01 to 2015-03-31	1,873,270	USD	90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	10,546,000	USD	366
2015-01-01 to 2015-12-31	15,112,000	USD	365
2014-01-01 to 2014-12-31	22,491,000	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-12-31	57,179,686	shares
At 2015-12-31	51,998,306	shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2016-12-31	6,634,311	USD
At 2015-12-31	37,926,988	USD
At 2014-12-31	65,458,518	USD
At 2013-12-31	33,214,870	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2016-12-31	2,412,000	USD
At 2015-12-31	1,197,000	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2016-12-31	240,890	USD
At 2015-12-31	321,574	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	-3,354,472	USD	92
2016-01-01 to 2016-12-31	-19,163,629	USD	366
2016-07-01 to 2016-09-30	-3,992,129	USD	92
2016-04-01 to 2016-06-30	-5,052,240	USD	91
2016-01-01 to 2016-03-31	-6,764,789	USD	91
2015-10-01 to 2015-12-31	-7,289,807	USD	92
2015-01-01 to 2015-12-31	-33,713,917	USD	365
2015-07-01 to 2015-09-30	-5,301,667	USD	92
2015-04-01 to 2015-06-30	-5,767,013	USD	91
2015-01-01 to 2015-03-31	-5,749,231	USD	90
2014-01-01 to 2014-12-31	-39,048,772	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	6,536,067	USD	366
2015-01-01 to 2015-12-31	9,055,885	USD	365
2014-01-01 to 2014-12-31	8,957,441	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	1,214,000	USD	366
2015-01-01 to 2015-12-31	825,000	USD	365
2014-01-01 to 2014-12-31	341,000	USD	365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	1,214,453	USD	366
2015-01-01 to 2015-12-31	824,827	USD	365
2014-01-01 to 2014-12-31	340,770	USD	365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	3,690	USD	92
2016-01-01 to 2016-12-31	23,479	USD	366
2016-07-01 to 2016-09-30	3,080	USD	92
2016-04-01 to 2016-06-30	6,555	USD	91
2016-01-01 to 2016-03-31	10,154	USD	91
2015-10-01 to 2015-12-31	4,253	USD	92
2015-01-01 to 2015-12-31	11,489	USD	365
2015-07-01 to 2015-09-30	-1,299	USD	92
2015-04-01 to 2015-06-30	12,422	USD	91
2015-01-01 to 2015-03-31	44,477	USD	90
2014-01-01 to 2014-12-31	22,046	USD	365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	-406,253	USD	92
2016-01-01 to 2016-12-31	-2,081,275	USD	366
2016-07-01 to 2016-09-30	-648,378	USD	92
2016-04-01 to 2016-06-30	-684,279	USD	91
2016-01-01 to 2016-03-31	-342,366	USD	91
2015-01-01 to 2015-12-31	59,853	USD	365
2014-01-01 to 2014-12-31	142,984	USD	365

Inspect the source

Entity: AMPIO PHARMACEUTICALS, INC. / CIK 0001411906
Captured: 2026-09-22 19:47 UTC
SEC response SHA-256: 661bdc81760eff21f73144c4212b3daf37fe49f00b5469e6e153f0c2138a63e3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001411906.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))